Evolus (EOLS) Free Cash Flow Growth (3y) (2020 - 2026)
Evolus (EOLS) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 9.86% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -18.92% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.82% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 45.60% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 39.19% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -82.02% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 18.94% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 114.21% |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn | 20.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.73% |
| Dec 31, 2025 | 47.59% |
| Sep 30, 2025 | 3.82% |
| Jun 30, 2025 | -6.46% |
| Mar 31, 2025 | 25.26% |
| Dec 31, 2024 | 38.05% |
| Sep 30, 2024 | 43.06% |
| Jun 30, 2024 | -34.45% |
| Mar 31, 2024 | -9.23% |
| Dec 31, 2023 | 30.09% |
| Sep 30, 2023 | 61.64% |
| Jun 30, 2023 | 2.93% |
| Mar 31, 2023 | 9.96% |
| Dec 31, 2022 | 16.17% |
| Sep 30, 2022 | 11.34% |
| Jun 30, 2022 | 13.29% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 9.70% |
| Sep 30, 2021 | -78.28% |
| Jun 30, 2021 | 69.00% |